Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 30, 2019 - Issue 6
Submit an article Journal homepage
585
Views
15
CrossRef citations to date
0
Altmetric
Psoriasis

Efficacy and survival of biologic agents in psoriasis: a practical real-life 12-year experience in a French dermatology department

Hélène RocheDepartment of Dermatology, University Hospital and EA3181, University of Franche Comté, Besançon, France;
,
Kevin BouillerDepartment of Internal Medicine, University Hospital, Besançon, France;
,
Eve PuzenatDepartment of Dermatology, University Hospital and EA3181, University of Franche Comté, Besançon, France;
,
Elise DevezaDepartment of Dermatology, University Hospital and EA3181, University of Franche Comté, Besançon, France;
,
Blandine RocheDepartment of Dermatology, University Hospital and EA3181, University of Franche Comté, Besançon, France;
,
Fabien PelletierDepartment of Dermatology, University Hospital and EA3181, University of Franche Comté, Besançon, France;
,
Alison van de LaakDepartment of Dermatology, University Hospital and EA3181, University of Franche Comté, Besançon, France;
,
Anne Sophie DupondDepartment of Dermatology, General Hospital, Trévenans, France
,
Charlée NardinDepartment of Dermatology, University Hospital and EA3181, University of Franche Comté, Besançon, France;
&
François AubinDepartment of Dermatology, University Hospital and EA3181, University of Franche Comté, Besançon, France; Correspondence[email protected]
 show all
Pages 540-544 | Received 23 Apr 2018, Accepted 16 May 2018, Published online: 08 Apr 2019

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Lluís Rusiñol, Elena Carmona-Rocha & Lluís Puig. (2023) Durability and long-term outcomes of biologic therapies in psoriasis. Expert Review of Clinical Immunology 0:0, pages 1-12.
Read now
Arzu Ataseven, Selami Aykut Temiz, Güllü Eren, İlkay Özer & Recep Dursun. (2022) Comparison of anti-TNF and IL-inhibitors treatments in patients with psoriasis in terms of response to routine laboratory parameter dynamics. Journal of Dermatological Treatment 33:2, pages 1091-1096.
Read now
Nishadh Sutaria & Shiu-Chung Au. (2021) Failure rates and survival times of systemic and biologic therapies in treating psoriasis: a retrospective study. Journal of Dermatological Treatment 32:6, pages 617-620.
Read now

Articles from other publishers (12)

Sara Mucherino, Concetta Rafaniello, Marianna Serino, Alessia Zinzi, Ugo Trama, Annalisa Capuano, Enrica Menditto & Valentina Orlando. (2023) Drug Utilization and Measurement of Medication Adherence: A Real World Study of Psoriasis in Italy. Pharmaceutics 15:12, pages 2647.
Crossref
Megumi Kishimoto, Mayumi Komine, Koji Kamiya, Junichi Sugai, Aya Kuwahara, Makiko Mieno & Mamitaro Ohtsuki. (2023) Drug Survival of Tumor Necrosis Factor-Alpha Inhibitors and Switched Subsequent Biologic Agents in Patients with Psoriasis: A Retrospective Study. Dermatology and Therapy 13:6, pages 1347-1360.
Crossref
Maria Letizia Musumeci, Andrea Calogero Trecarichi, Giuliana Caruso, Alice Aleo, Helga Platania & Giuseppe Micali. (2022) Long lasting response to anti‐tumor necrosis factor α agents in psoriasis: A real life experience. Dermatologic Therapy 35:12.
Crossref
Iulia-Alexandra Paliu, Simona-Laura Ianosi, Adina Turcu-Stiolica, Catalina-Gabriela Pisoschi, Luminita-Georgeta Predoi & Andrei-Adrian Tica. (2022) Vitamin D May Be Connected with Health-Related Quality of Life in Psoriasis Patients Treated with Biologics. Journal of Personalized Medicine 12:11, pages 1857.
Crossref
Laida Elberdín, Rosa M. Fernández-Torres, Sabela Paradela, María Mateos, Eva Blanco, Vanesa Balboa-Barreiro, María I. Gómez-Besteiro, Maria Outeda, Isabel Martín-Herranz & Eduardo Fonseca. (2022) Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago. Dermatology and Therapy 12:3, pages 761-770.
Crossref
Melinda J. Gooderham, Charles Lynde, Irina Turchin, Miriam Avadisian, Melanie Labelle & Kim A. Papp. (2021) Real‐world, long‐term treatment patterns of commonly used biologics in Canadian patients with moderate‐to‐severe chronic plaque psoriasis. The Journal of Dermatology 49:1, pages 95-105.
Crossref
Marcus Schmitt-Egenolf, Jonatan Freilich, Natalia M. Stelmaszuk-Zadykowicz, Eydna Apol, Jes B. Hansen & Lars-Åke Levin. (2021) Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study. Dermatology and Therapy 11:6, pages 2107-2121.
Crossref
Martina Kojanova, Jorga Fialova, Petra Cetkovska, Thomas Dolezal, Iva Lomicova, Petr Arenberger & Spyridon Gkalpakiotis. (2021) Demographic data, comorbidities, quality of life, and survival probability of biologic therapy associated with sex‐specific differences in psoriasis in the Czech Republic. Dermatologic Therapy 34:2.
Crossref
Yu-Chen Chen, Yi-Ting Huang, Chao-Chun Yang, Edward Chia-Cheng Lai, Cheng-Han Liu, Chao-Kai Hsu, Tak-Wah Wong, Sheau-Chiou Chao, Hamm-Ming Sheu & Chaw-Ning Lee. (2020) Real-world efficacy of biological agents in moderate-to-severe plaque psoriasis: An analysis of 75 patients in Taiwan. PLOS ONE 15:12, pages e0244620.
Crossref
Olga Yu. Olisova & Ekaterina M. Anpilogova. (2020) Systemic treatment of psoriasis: from methotrexate to biologics. Vestnik dermatologii i venerologii 96:3, pages 7-26.
Crossref
L.S. van der Schoot, J.M.P.A. van den Reek, J.M.M. Groenewoud, M.E. Otero, M.D. Njoo, P.M. Ossenkoppele, J.M. Mommers, M.I.A. Koetsier, M.A.M. Berends, W.P. Arnold, B. Peters, M.P.M. Andriessen, C.W. Den Hengst, A.L.A. Kuijpers & E.M.G.J. de Jong. (2019) Female patients are less satisfied with biological treatment for psoriasis and experience more side‐effects than male patients: results from the prospective BioCAPTURE registry. Journal of the European Academy of Dermatology and Venereology 33:10, pages 1913-1920.
Crossref
L. Mercieca, D. LaveryR.B. WarrenC.E.M. Griffiths. (2019) Long‐term, real‐world efficacy of biologics for psoriasis: a single centre's experience. British Journal of Dermatology 181:3, pages 599-601.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.